Short Versus Long Duration of Dual Antiplatelet Therapy After Second-Generation Drug-Eluting Stents Implantation in Patients with Diabetes Article (Faculty180)

cited authors

  • Gangwani, Manesh K; Aziz, Muhammad; Chacko, Paul; Mahmood, Asif; Ali, Muhammad; Priyanka, Fnu; Munir, Siraj; Aziz, Abeer; Sagheer, Shazib; Lee-Smith, Wade; Parkash, Om; Rai, Devesh; Baibhav, Bipul; Aronow, Wilbert S

description

  • Duration of dual antiplatelet therapy (DAPT) in patients undergoing percutaneous coronary intervention (PCI) remains uncertain, with increasing data suggestive of acceptable short-term duration. Metabolically accelerated atherosclerosis associated with diabetes makes it essential to study short-term DAPT in this subgroup. With limited studies determining optimal DAPT strategies after second-generation stents in this subset, we aimed to establish the optimal duration of DAPT in the diabetic population using second-generation stents.

authors

published in

start page

  • e416

end page

  • e425

volume

  • 30